ReviewSkeletal radiology2026
Adhesive capsulitis embolization: a narrative review.
Review in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adhesive capsulitis is a painful shoulder disorder characterized by progressive stiffness and loss of range of motion, affecting approximately 2%-5% of the general population. Adhesive capsulitis embolization (ACE) is a minimally invasive endovascular technique that targets abnormal neovascularization associated with capsular inflammation. This narrative review summarizes the current literature on ACE for adhesive capsulitis, focusing on procedural technique and reported clinical outcomes. Eleven published clinical studies comprising 422 patients were identified and summarized descriptively. Across these studies, embolization was associated with improvement in pain, functional outcomes, and shoulder range of motion, with no major complications reported. However, definitions of technical success, clinical success, minimal clinically important difference (MCID), outcome measures, and follow-up duration varied between studies, limiting direct comparison. Although early short- to mid-term results are promising, the available evidence remains limited. Larger prospective studies with longer follow-up duration, standardized outcome reporting, stage stratification, and appropriate control groups are needed to define the true value of ACE in the management of adhesive capsulitis.
Indexed as
Identifiers
42489685What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.